Endoscopic versus Shunt Treatment of Hydrocephalus in Infants
What is the goal of the study?
Hydrocephalus is a neurological condition that primarily affects infants under one year of age. Shunt placement and Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization (ETV+CPC) are commonly used treatments for hydrocephalus. It is unknown if one of these procedures is better than the other. This multi-centered randomized controlled trial aims to understand the effects of shunt vs. ETV+CPC on brain function. Additionally, researchers will compare measures of treatment performance to assess long-term outcomes of both procedures.
Who can participate in the study?
This study may be a good fit for: -Eligible patients are 24 months or younger (corrected age) and undergoing surgery for treatment of hydrocephalus -Patients must be able to have either surgical procedure (Shunt or Endoscopic Third Ventriculostomy + Choroid Plexus Cauterization). Your neurosurgeon will determine whether you meet eligibility criteria and will discuss the ESTHI Study with you if they believe it would be a good fit for your child.